法瑟姆制药 PHAT
$5.25 +$0.17 (+3.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.25 0.00%
开盘$5.26
昨收$5.08
当日区间$5.04 – $5.31
成交量1.77M
市值$426.78M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$84.72M+71.1% YoY
营业利润-$85,000.00+99.4% YoY
净利润-$13.90M+53.6% YoY
摊薄每股收益-$0.16+61.0% YoY
自由现金流$1.73M+112.2% YoY
经营现金流$1.84M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率80.7%
营业利润率-9.3%
净利率-30.2%
资产收益率-28.4%
流动比率1.76
负债/资产比率200.8%
现金及投资$184.56M
总负债$167.28M
净现金（净负债）$17.27M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $84.72M | $74.27M | $58.30M | $175.11M | $57.58M |
| 营业总收入 | $84.72M | $74.27M | $58.30M | $175.11M | $57.58M |
| 营业成本 | $18.37M | $15.10M | $12.00M | $22.60M | $7.65M |
| 毛利润 | $66.36M | $59.18M | $46.31M | $152.51M | $49.94M |
| 营业费用 | $66.44M | $63.14M | $61.78M | $312.50M | $55.86M |
| 销售及管理费用 | $57.70M | $55.33M | $54.01M | $279.72M | $48.37M |
| 研发费用 | $8.75M | $7.81M | $7.77M | $32.78M | $7.49M |
| 营业利润 | -$85,000.00 | -$3.97M | -$15.48M | -$159.99M | -$5.93M |
| 非经营性利息净收入（支出） | -$13.79M | -$13.59M | -$14.06M | -$61.07M | -$15.22M |
| 非经营性利息收入 | $1.60M | $1.51M | $1.74M | $7.04M | $1.20M |
| 非经营性利息支出 | $15.39M | $15.10M | $15.80M | $68.12M | $16.42M |
| 其他收入（支出） | -$25,000.00 | -$24,000.00 | -$831,000.00 | -$190,000.00 | -$5,000.00 |
| 其他非经营性收入（支出） | -$25,000.00 | -$24,000.00 | -$831,000.00 | -$190,000.00 | -$5,000.00 |
| 税前利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 净利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 持续经营利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 归属母公司净利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 归属普通股股东净利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 基本每股收益 | -$0.16 | -$0.21 | -$0.37 | -$3.03 | -$0.29 |
| 摊薄每股收益 | -$0.16 | -$0.21 | -$0.37 | -$3.03 | -$0.29 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $345.02M | $327.08M | $305.12M | $259.15M | $259.15M |
| 流动资产合计 | $308.01M | $295.92M | $276.57M | $228.97M | $228.97M |
| 现金及现金等价物与短期投资 | $184.56M | $182.48M | $180.90M | $129.97M | $129.97M |
| -现金及现金等价物 | $184.56M | $182.48M | $180.90M | $129.97M | $129.97M |
| 应收款 | $107.60M | $97.42M | $80.72M | $78.13M | $78.13M |
| -应收账款 | $107.60M | $97.42M | $80.72M | $78.13M | $78.13M |
| 存货 | $7.63M | $7.71M | $6.51M | $5.52M | $5.52M |
| 其他流动资产 | $8.22M | $8.30M | $8.44M | $15.35M | $15.35M |
| 非流动资产合计 | $37.01M | $31.16M | $28.55M | $30.18M | $30.18M |
| 固定资产净值 | $3.25M | $3.38M | $3.52M | $3.67M | $3.67M |
| -固定资产原值 | $3.25M | $3.38M | $3.52M | $7.14M | $7.14M |
| 其他非流动资产 | $33.76M | $27.78M | $25.03M | $26.51M | $26.51M |
| 负债合计 | $692.66M | $671.35M | $642.08M | $697.32M | $697.32M |
| 流动负债合计 | $174.90M | $153.78M | $125.04M | $132.04M | $132.04M |
| 应付款 | $11.11M | $5.36M | $6.37M | $4.98M | $4.98M |
| -应付账款 | $11.11M | $5.36M | $6.37M | $4.98M | $4.98M |
| 一年内应计费用 | $108.21M | $97.16M | $75.78M | $76.82M | $76.82M |
| 短期债务及融资租赁负债 | $673,000.00 | $670,000.00 | $667,000.00 | $648,000.00 | $648,000.00 |
| -一年内到期融资租赁负债 | $673,000.00 | $670,000.00 | $667,000.00 | $648,000.00 | $648,000.00 |
| 其他流动负债 | $40.52M | $37.28M | $33.02M | $34.75M | $34.75M |
| 非流动负债合计 | $517.76M | $517.57M | $517.03M | $565.27M | $565.27M |
| 长期债务及融资租赁负债 | $167.28M | $166.44M | $165.64M | $211.15M | $211.15M |
| -长期债务 | $165.54M | $164.59M | $163.68M | $209.09M | $209.09M |
| -长期融资租赁负债 | $1.74M | $1.86M | $1.96M | $2.07M | $2.07M |
| 其他非流动负债 | $350.47M | $351.13M | $351.40M | $354.12M | $354.12M |
| 股东权益合计 | -$347.64M | -$344.27M | -$336.96M | -$438.17M | -$438.17M |
| 股东权益 | -$347.64M | -$344.27M | -$336.96M | -$438.17M | -$438.17M |
| 股本 | $8,000.00 | $8,000.00 | $7,000.00 | $6,000.00 | $6,000.00 |
| -普通股 | $8,000.00 | $8,000.00 | $7,000.00 | $6,000.00 | $6,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.20B | $1.19B | $1.18B | $1.05B | $1.05B |
| 留存收益 | -$1.55B | -$1.53B | -$1.51B | -$1.48B | -$1.48B |
| 减：库存股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -累计折旧 | – | – | – | -$3.48M | -$3.48M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $1.84M | -$1.93M | -$15.65M | -$166.78M | -$5.00M |
| 持续经营经营活动现金流净额 | $1.84M | -$1.93M | -$15.65M | -$166.78M | -$5.00M |
| 持续经营净利润 | -$13.90M | -$17.58M | -$30.37M | -$221.25M | -$21.15M |
| 持续经营损益 | $0.00 | $0.00 | $829,000.00 | – | – |
| 折旧、折耗与摊销 | $120,000.00 | $114,000.00 | $110,000.00 | $633,000.00 | $128,000.00 |
| 其他非现金项目 | $4.73M | $6.19M | $6.70M | $37.22M | $6.90M |
| 营运资金变动 | $4.05M | $2.63M | $1.55M | -$12.38M | $4.05M |
| -应收款变动 | -$10.18M | -$16.70M | -$2.60M | -$39.33M | -$22.34M |
| -存货变动 | -$6.34M | -$3.96M | $665,000.00 | -$11.78M | $2.00M |
| -预付资产变动 | $81,000.00 | $132,000.00 | $6.92M | $5.51M | -$2.13M |
| -应付账款及应计费用变动 | $20.98M | $23.16M | -$3.28M | $34.23M | $27.64M |
| -其他流动资产变动 | -$478,000.00 | $0.00 | -$171,000.00 | -$1.22M | -$1.22M |
| -其他营运资金变动 | -$8,000.00 | -$5,000.00 | $10,000.00 | $222,000.00 | $90,000.00 |
| 投资活动现金流净额 | -$110,000.00 | -$44,000.00 | -$61,000.00 | -$229,000.00 | -$87,000.00 |
| 持续经营投资活动现金流净额 | -$110,000.00 | -$44,000.00 | -$61,000.00 | -$229,000.00 | -$87,000.00 |
| 固定资产购置及出售净额 | -$110,000.00 | -$44,000.00 | -$61,000.00 | -$229,000.00 | -$87,000.00 |
| 筹资活动现金流 | $351,000.00 | $3.55M | $66.64M | -$288,000.00 | -$97,000.00 |
| 持续经营筹资活动现金流净额 | $351,000.00 | $3.55M | $66.64M | -$288,000.00 | -$97,000.00 |
| 债务发行及偿还净额 | $0.00 | $0.00 | -$55.80M | $0.00 | $0.00 |
| 普通股发行净额 | $0.00 | $0.00 | $121.97M | $0.00 | $0.00 |
| 股票期权行使所得 | $372,000.00 | $3.55M | $591,000.00 | $1.64M | $1.27M |
| 其他筹资费用净额 | -$21,000.00 | $0.00 | -$128,000.00 | -$1.93M | -$1.36M |
| 期末现金余额 | $187.42M | $185.34M | $183.77M | $132.83M | $132.83M |
| 现金净变动 | $2.08M | $1.58M | $50.93M | -$167.29M | -$5.19M |
| 期初现金余额 | $185.34M | $183.77M | $132.83M | $300.13M | $138.02M |
| 自由现金流 | $1.73M | -$1.97M | -$15.71M | -$167.00M | -$5.09M |
暂无评论——快来第一个聊聊 PHAT。